Expand BIOA Menu
BIOA MENU

BIOA Stock Summary and Trading Ideas (Bioage Labs | NASDAQ:BIOA)

Charts for Today's Stock Price and Implied Volatility in Bioage Labs

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for BIOA by Theoretical Edge and Win Rates

Sentiment

News

Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA

PRNewswire (Mon, 10-Mar 9:30 PM ET)

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

PRNewswire (Mon, 10-Mar 6:33 PM ET)

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action BIOA

Globe Newswire (Mon, 10-Mar 4:43 PM ET)

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Business Wire (Mon, 10-Mar 4:41 PM ET)

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery Contact Levi & Korsinsky

Globe Newswire (Mon, 10-Mar 1:05 PM ET)

DEADLINE ALERT for REGN and BIOA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Globe Newswire (Mon, 10-Mar 10:30 AM ET)

BIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged to Contact BFA Law before the Expiration of Today's Class Action Deadline

Globe Newswire (Mon, 10-Mar 8:31 AM ET)

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA

PRNewswire (Mon, 10-Mar 5:45 AM ET)

BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PRNewswire (Mon, 10-Mar 1:57 AM ET)

Weight-loss drug battle: Who are the latest players involved

Seeking Alpha News (Sat, 8-Mar 1:30 PM ET)

Trading Statistics

Key Ratios

Bioage Labs (BIOA) Frequently Asked Questions

What does Bioage Labs do?

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

What symbol and exchange does Bioage Labs shares trade?

Bioage Labs trades on the NASDAQ stock market under the symbol BIOA.

What is Bioage Labs stock price doing today?

As of March 10, 2025, BIOA stock price declined to $4.33 with 105,824 million shares trading.

What is Bioage Labs's Beta?

BIOA has a beta of 2.73, meaning it tends to be more sensitive to market movements. BIOA has a correlation of 0.02 to the broad based SPY ETF.

How much is Bioage Labs worth?

BIOA has a market cap of $155.09 million. This is considered a Micro Cap stock.

What are the top ETFs holding Bioage Labs?

The top ETF exchange traded funds that BIOA belongs to (by Net Assets): VTI, IWM, VXF, FESM, IWO.

What are the support and resistance levels for Bioage Labs (BIOA)?

BIOA support price is $4.35 and resistance is $4.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOA shares will trade within this expected range on the day.